抗人c-erbB2单克隆抗体的制备及其特异性鉴定

Preparation of monoclonal antibody (against) human c-erbB2 and identification of its specificity

目的:制备小鼠抗人c-erbB2mAb,并进行特异性鉴定。方法:应用计算机软件分析人源c-erbB2抗原表位,人工合成羧基端含优势表位的13肽,与钥孔戚血蓝蛋白(KLH)偶联后,免疫BALB/c小鼠。取免疫小鼠脾细胞与Sp2/0骨髓瘤细胞常规融合,依次经HAT选择培养、间接ELISA法、克隆化和免疫组化染色法筛选出稳定分泌抗天然人源c-erbB2mAb的杂交瘤细胞株。用交叉反应试验和阻断试验检测mAb的特异性。结果:获得1株可稳定分泌抗天然人源c-erbB2抗体的杂交瘤细胞株。该mAb与已知的c erbB2抗原阳性的乳腺癌标本起反应;与其他不表达c-erbB2分子的细胞不起反应。用合成的13肽阻断后,失去与c-erbB2抗原的反应性。结论:用合成的13肽作为免疫原成功地制备出1株抗c-erbB2的mAb。

AIM: To prepare monoclonal antibody(mAb) against human c-erbB2 and identify its specificity. METHODS: The epitope of human c-erbB2 antigen was analyzed by using computer software and a immunodominant epitope at the carboxyl-terminal was selected. A peptide consisting of 13 amino acids was synthesized and coupled with keyholelimpet hemocyanin (KLH), and then it was used to immunize BLAB/c mice. The splenocytes of the immunized mice were fused with Sp2/0 cells routinely and the hybridoma cells were selected by HAT selected culture, indirect ELISA, and immunohistochemical staining, and cloned by limiting dilution. The specificity of the mAb was identified by cross-reaction test and blocking test. RESULTS: A hybridoma cell line SC8C1, stably secreting anti-c-erbB2 mAb was obtained. The mAb SC8C1 could react to breast cancer tissue expressing c-erbB2 molecule but did not react to other c-erbB2-negtive cells. The mAb will lose the activity after being blocked with synthesized 13 peptide. CONCLUSION: A anti-c-erbB2 mAb SC8C1 is prepared successfully using synthesized 13 peptide as immunogen.